AMRX - Amneal Quarterly EPS earnings growth

Amneal Pharmaceuticals (AMRX) - corporate logo

The investment potential of Amneal Pharmaceuticals (AMRX) was constrained by raw material shortages from Asia and logistical disruptions. Quarterly EPS progress clearly demonstrates these fluctuations, where -985.60 records a new level. Stability is returning through the implementation of robotic filling lines and the launch of high-margin biosimilars with injectable forms, which effectively offsets pricing pressure in the core drug segment.

amneal.com (AMRX) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/18/2026

Analytical breakdowns and data insights for company amneal.com (AMRX)

Summary company analysis:amneal.com - AMRX
Manufactured product of Amneal Pharmaceuticals

Finding a balance between share price and asset quality requires an analysis of net profit per share dynamics. This indicator measures the quarterly rate of change in EPS, determining the business's margin of safety during market contraction. For Amneal Pharmaceuticals (AMRX), profit growth confirms the effectiveness of its expansion into the biosimilars and complex injectables segment. Positive momentum indicates a successful reduction of the debt load. Evaluate the current quarterly EPS growth value to forecast capital stability.

Analysis of competing companies

HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|PRGO (Perrigo Company PLC) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ALVO (Alvotech S.A.)|Liquidia Technologies - Year-over-year earnings per share growth for the last twelve months|Galapagos Corp - Quarterly EPS earnings growth|ANIP (ANI Pharmaceuticals) - Year-over-year earnings per share growth for the last 12 months|MannKind Corp. (MNKD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Quarterly EPS earnings growth|SPRY: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TBPH|Year-over-year net earnings per share change for the last twelve months Aquestive Therapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Year-over-year earnings per share growth for the last 12 months|TNXP - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months SXT Pharmaceuticals SXTC|EPRX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bioharvest.com (BHST)|Year-over-year net earnings per share growth for the last 12 months EXOZ|ORMP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ABVC (ABVC BioPharma, Inc)|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|FibroGen Corp (FGEN) - Year-over-year net earnings per share growth for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Year-over-year earnings per share growth for the last twelve months|Rani Therapeutics (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Earnings per share growth in annualized terms for the last twelve months rallybio.com RLYB|Quarterly EPS earnings growth LEXX|PULM: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings Ltd - Year-over-year net earnings per share growth for the last 12 months|APM - Year-over-year net earnings per share growth for the last 12 months|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)